Patients with Opioid Use Disorder Treated in Emergency Departments Shed Light on Their Unmet Needs and Opportunities to Improve Care in Yale-Led Study Published in JAMA Network Open
To better understand the experiences of patients with OUD on receiving care in the ED and to identify opportunities to improve care, Yale researchers led a collaboration with New York University, John’s Hopkins University, University of Cincinnati, Mount Sinai Hospital in New York, and the University of Washington. Between June 2018 and January 2019. They conducted focus groups with ED patients across six academic, community, and public safety net EDs in Baltimore, MD, Cincinnati, OH, New York City, NY, Seattle, WA and Claremont, NH, as part of two NIDA Clinical Trials Network studies.
Stressed Out and Locked-Down During Pandemic, New Yorkers Craved Alcohol, YSPH Study Finds
As New York state’s lockdown orders wore on in the early months of the COVID-19 pandemic, residents increasingly felt cravings for alcohol — and reported subsequently misusing it, a new study from scientists at the Yale School of Public Health and Stony Brook University has found.
Here’s how Connecticut can move beyond the harm of the War on Drugs
In the 1990s, then-Senator Joe Biden and others pushed a War on Drugs, a war that had a tremendous negative impact on our state. Prison populations soared; over a third of young men of color were under criminal justice supervision; and drug use and attendant public health consequences proceeded unabated.Source: CT Mirror
Pandemic-based Approach to Methadone Treatment Restrictions Should Remain, YSPH Study Finds
When the COVID-19 pandemic ripped through New England and the rest of the United States in early 2020, substance use disorder treatment centers were forced to make massive changes to minimize the spread of coronavirus.
The Overdose Crisis: Harm Reduction in U.S. Health Policy
On May 20, Yale’s Department of Internal Medicine and Program in Addiction Medicine hosted its first event on Clubhouse, a social networking app that allows members to gather in audio chat rooms and discuss issues in a live podcast style. The event focused on the drug overdose in the United States and incorporation of harm reduction into U.S. health policy and practice.
Op-Ed: Yale study on lung disease forecasts dire consequences for flavor bans
A new study from Yale School of Public Health should serve as a warning to e-cigarette opponents and public health officials pushing e-cigarette flavor bans and restrictions around the country. The Yale research revealed that higher levels of e-cigarette and marijuana use did not result in higher rates of e-cigarette or vaping-related lung injuries (EVALI). EVALI made headlines during 2019 and was responsible for at least 2,800 hospitalizations and 68 deaths.Source: The Center Square
Ending Stigma, Saving Lives: Yale Doctors Take on Opioid Addiction
On the lapel of her blazer, Dr. Gail D’Onofrio wears a button bearing one word with a line through it: stigma. D’Onofrio, who chairs Yale’s Department of Emergency Medicine, works to improve outcomes for people with opioid use disorder, and she’s on a crusade against stigma for a simple reason: social fear hinders treatment.
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
Yale Researchers Awarded Grant to Study Smoking Treatment in People With HIV
Drs. E. Jennifer Edelman and Steven L. Bernstein received a grant award to address tobacco smoking addiction among people with HIV. The National Cancer Institute grant, totaling more than $3 million, supports a five-year research project.
Yale and Mayo Clinic Awarded FDA Grant to Study Opioid Prescribing and Use
Yale University and Mayo Clinic have been awarded a grant for up to $5.3 million over two years by the U.S. Food and Drug Administration (FDA) to study patients’ experiences with pain and use of opioids prescribed for acute pain. This project is part of the Center of Excellence in Regulatory Science and Innovation (CERSI), a joint effort between Yale, Mayo Clinic, and the FDA. The study will be conducted in collaboration with Regional Health of Rapid City, S.D., and University of Alabama at Birmingham (UAB).